Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bluejay Diagnostics (BJDX) Depreciation and Depletion (2022 - 2023)

Bluejay Diagnostics (BJDX) has disclosed Depreciation and Depletion for 2 consecutive years, with $22342.0 as the latest value for Q4 2023.

  • Quarterly Depreciation and Depletion fell 27.18% to $22342.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $648708.0 through Dec 2023, up 314.25% year-over-year, with the annual reading at $74182.0 for FY2025, 1.9% down from the prior year.
  • Depreciation and Depletion hit $22342.0 in Q4 2023 for Bluejay Diagnostics, down from $253174.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $253175.0 in Q2 2023 to a low of $22342.0 in Q4 2023.